Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02889003 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Second STOP After Pioglitazone Priming in CML Patients

Study acronym: PIO2STOP
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Dec 2021 to Dec 2027
    • Study sites: 4 to 6
    • Study completion date: Dec 2021 to Dec 2028
    • Collaborators shortened, about 3 words
    v3
  2. Trial status: Not Yet Recruiting to Recruitingv2 Show 5 more changesShow less
    • Primary and study completion dates: Oct 2018 to Dec 2021
    • Start date: Oct 2016 to Dec 2016
    • Study sites: 1 to 4
    • Eligibility criteria expanded, about 12 words
    • Collaborators expanded, about 3 words
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Single-center study, prospective, phase II trial. The study objectives are : * To assess safety and pharmacokinetics of the combination of PIO and TKI in CML subjects who experience a loss of MMR following a first TKI discontinuation. * To assess survival without loss of MMR over a 12 months period following a second TKI discontinuation in subjects who achieve or maintain \< MR4.5 with the combination PIO and TKI administered for at least 6 months.
Trial Details
NCT Number NCT02889003
Lead Sponsor Versailles Hospital
Conditions
(from sponsor)		 Chronic Myeloid Leukemia (CML)
Related terms Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Enrollment 26 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov